| 94.99 94.99 (0%) | 04-24 15:47 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 1-year : | ||
| Resists | First : | Second : | ||
| Pivot price | ||||
| Supports | First : | Second : | ||
| MAs | MA(5) : | MA(20) : | ||
| MA(100) : | MA(250) : | |||
| MACD | MACD : | Signal : | ||
| %K %D | K(14,3) : | D(3) : | ||
| RSI | RSI(14): | |||
| 52-week | High : | Low : | ||
| If tomorrow: | Open lower | Open higher |
| High: | - | - |
| Low: | - | - |
| Close: | - | - |
Magellan Health, Inc. (MGLN) provides comprehensive healthcare management services across the United States. Its operations are organized into two main divisions: Healthcare and Pharmacy Management. The Healthcare segment specializes in administering specific health services, including "carve-out" management for behavioral health, employee assistance programs, and other niche medical fields like diagnostic imaging, musculoskeletal care, cardiac services, and physical medicine. This segment also collaborates with state Medicaid agencies and the Centers for Medicare & Medicaid Services (CMS) to oversee care for beneficiaries within Medicaid and Medicare programs, encompassing long-term support. These services are delivered through a vast network of medical and behavioral health professionals, clinics, hospitals, nursing facilities, home care agencies, and other ancillary providers. The Pharmacy Management segment offers products and solutions for the clinical and financial oversight of pharmaceuticals covered under both medical and pharmacy benefits. Its offerings include pharmacy benefit management (PBM) services, pharmaceutical dispensing, administration of pharmacy benefits for state Medicaid and other government-sponsored initiatives, clinical and formulary management strategies, medical pharmacy management programs, and integrated solutions for complex specialty medications. Magellan Health serves a broad clientele, including health plans, managed care organizations, employers, labor unions, third-party administrators, state and federal government entities (including military agencies), exchanges, brokers, and consultants. Founded in 1969 and based in Phoenix, Arizona, Magellan Health, Inc. has operated as a subsidiary of Centene Corporation since January 4, 2022.
Tue, 22 Nov 2022
Centene Selling Magellan Specialty Health to Evolent Health - HCI Innovation Group
Sat, 19 Nov 2022
Allen F Wise Net Worth (2026) - GuruFocus
Mon, 08 Aug 2022
Magellan Health Appoints Tom Britt as Chief Information Officer - Business Wire
Mon, 20 Dec 2021
Magellan Healthcare and DUOS to Offer Personal Assistant for Aging and Behavioral Health Support - The Valley Ledger
Thu, 12 Nov 2020
Armed Forces Services Corporation (AFSC) Rebrands as Magellan Federal - Business Wire
Thu, 03 Sep 2020
Magellan Health Appoints David Bourdon as Chief Financial Officer of Magellan Health - Business Wire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Plans
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | (%) |
| Held by Institutions | (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | |
| EPS Est Next Qtrly | |
| EPS Est This Year | |
| EPS Est Next Year | |
| Book Value (p.s.) | |
| Profit Margin | % |
| Operating Margin | % |
| Return on Assets (ttm) | % |
| Return on Equity (ttm) | % |
| Qtrly Rev. Growth | % |
| Gross Profit (p.s.) | |
| Sales Per Share | |
| EBITDA (p.s.) | |
| Qtrly Earnings Growth | % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | |
| PEG Ratio | |
| Price to Book value | |
| Price to Sales | |
| Price to Cash Flow |
| Dividend | |
| Forward Dividend | |
| Dividend Yield | 0% |
| Dividend Pay Date | |
| Ex-Dividend Date |
|
|
|
|
|
|
|
|
|